Choreo, LLC Biogen Inc. Transaction History

Choreo, LLC

$5.94 Billion
Q2 2024

A detailed history of Choreo, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Choreo, LLC holds 1,280 shares of BIIB stock, worth $222,451. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,280

Holding current value

$222,451

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$190.52 - $236.72 $243,865 - $303,001	1,280 New	1,280 $296,000
Q3 2018 Jun 04, 2020	SELL	$293.51 - $383.83 $286,759 - $375,001	-977 Closed	0 $0
Q2 2018 Jun 04, 2020	BUY	$257.52 - $306.91 $34,765 - $41,432	135 Added 16.03%	977 $284,000
Q1 2018 Jun 04, 2020	SELL	$260.13 - $367.91 $3,641 - $5,150	-14 Reduced 1.64%	842 $231,000
Q4 2017 Jun 04, 2020	BUY	$307.64 - $344.58 $263,339 - $294,960	856 New	856 $273,000
Q4 2016 Jun 04, 2020	SELL	N/A	-1,270 Closed	0 $0
Q3 2016 Jun 04, 2020	BUY	N/A	66 Added 5.48%	1,270 $398,000
Q2 2016 Jun 04, 2020	BUY	N/A	329 Added 37.6%	1,204 $291,000
Q1 2016 Jun 04, 2020	BUY	N/A	875 New	875 $228,000
Q2 2014 Jun 04, 2020	SELL	N/A	-942 Closed	0 $0
Q1 2014 Jun 04, 2020	BUY	N/A	942	942 $288,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Choreo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Choreo, LLC with notifications on news.

Account